DRUG-DRUG INTERACTION (DDI)
Clinical trials for DRUG-DRUG INTERACTION (DDI) explained in plain language.
Never miss a new study
Get alerted when new DRUG-DRUG INTERACTION (DDI) trials appear
Sign up with your email to follow new studies for DRUG-DRUG INTERACTION (DDI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests a new drug called zanzalintinib, alone or with other immune-boosting drugs, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find safe doses and see if the combination can shrink tumors or slow their growth.…
Matched conditions: DRUG-DRUG INTERACTION (DDI)
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New antibiotic combo tested in healthy volunteers – no cure yet
Knowledge-focused Recruiting nowThis early-stage study tests a new antibiotic combination (ceftibuten-ledaborbactam) in 46 healthy adults aged 18-55. The goal is to check safety and how the drug moves through the body, not to treat any disease. Participants will stay at a clinic for several days and have follow…
Matched conditions: DRUG-DRUG INTERACTION (DDI)
Phase: PHASE1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New drug safety check: how does JP-1366 mix with heart meds?
Knowledge-focused Recruiting nowThis early-stage study is checking if a new drug called JP-1366 is safe when taken with common heart medications like clopidogrel, aspirin, atorvastatin, and apixaban. About 96 healthy adults will take part to see how these drugs interact in the body. The goal is to gather import…
Matched conditions: DRUG-DRUG INTERACTION (DDI)
Phase: PHASE1 • Sponsor: Onconic Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC